Class A scavenger receptor promotes osteoclast differentiation via the enhanced expression of receptor activator of NF-κB (RANK)

Biochemical and Biophysical Research Communications

Volumn 391, Issue 4, 2010, Pages 1675-1680

  Takemura, Kenichi ^a   Sakashita, Naomi ^a   Fujiwara, Yukio ^a   Komohara, Yoshihiro ^a   Lei, XiaoFeng ^a   Ohnishi, Koji ^a   Suzuki, Hiroshi ^b   Kodama, Tatsuhiko ^c   Mizuta, Hiroshi ^a   Takeya, Motohiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Osteoclast; RANK; SR A

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CD135 ANTIGEN; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYTOPLASM PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SCAVENGER RECEPTOR A; TRANSCRIPTION FACTOR NFAT;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMUR; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MALE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BONE REMODELING; CELL DIFFERENTIATION; MICE; MICE, MUTANT STRAINS; OSTEOCLASTS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SCAVENGER RECEPTORS, CLASS A;

MUS;

EID: 74449087310     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.126     Document Type: Article

References (28)

1. Yagi T., Miyamoto T., Toyama Y., and Suda T. Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells. J. Bone Miner. Metab. 24 (2006) 355-358
2. Miyamoto T., Arai F., Ohneda O., Suda T., et al. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 15 (2000) 4335-4343
3. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
4. Lee J., Kim K., Kim J.H., Jin H.M., and Lee S.H. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107 (2006) 2686-2693
5. Ikeda F., Nishimura R., Matsubara T., Tanaka S., and Reddy S.V. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114 (2004) 463-465
6. Luchin A., Purdom G., Murphy K., Cassady A.I., et al. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J. Bone Miner. Res. 15 (2000) 451-460
7. Chellaiah M.A., Kizer N., Biswas R., Alvarez U., Strauss-Schoenberger J., Rifas L., Rittling S.R., Denhardt D.T., and Hruska K.A. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol. Biol. Cell 14 (2003) 173-189
8. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000) 275-286
9. Ledgerwood E.C., Pober J.S., and Bradley J.R. Recent advances in the molecular basis of TNF signal transduction. Lab. Invest. 79 (1999) 1041-1050
10. Tsujita K., Kaikita K., Hayasaki T., Honda T., Kobayashi H., Sakashita N., et al. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction. Circulation 115 (2007) 1904-1911
11. Kobayashi H., Sakashita N., Okuma T., Terasaki Y., Tsujita K., Suzuki H., et al. Role of SR-A in hyperoxic lung injury. J. Pathol. 212 (2007) 38-46
12. Platt N., Haworth R., Darley L., and Gordon S. The many roles of the class A macrophage scavenger receptor. Int. Rev. Cytol. 212 (2002) 1-40
13. Tomokiyo R., Jinnouchi K., Honda M., Wada Y., Hiraoka T., et al. Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 161 (2002) 123-132
14. Kamada N., Kodama T., and Suzuki H. Macrophage scavenger receptor (SR-A I/II) deficiency reduced diet-induced atherosclerosis in C57BL/6J mice. J. Atheroscler. Thromb. 8 (2001) 1-6
15. Fraser I., Hughes D., and Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364 (1993) 343-346
16. Daugherty A., Whitman S.C., Block A.E., and Rateri D.L. Polymorphism of class A scavenger receptors in C57BL/6 mice. J. Lipid. Res. 41 (2000) 1568-1577
17. Sakashita N., Miyazaki A., Takeya M., Horiuchi S., Chang T.Y., et al. Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am. J. Pathol. 156 (2000) 227-236
18. Lin Y.L., de Villiers W.J., Garvy B., Post S.R., Safadi F.F., et al. The effect of class A scavenger receptor deficiency in bone. J. Biol. Chem. 282 (2007) 4653-4660
19. Sharma S.M., Bronisz A., Hu R., Patel K., Mansky K.C., Sif S., and Ostrowski M.C. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J. Biol. Chem. 282 (2007) 15921-15929
20. Coller S.P., and Paulnock D.M. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J. Leukoc. Biol. 70 (2001) 142-148
21. Cotena A., Gordon S., and Platt N. The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis. J. Immunol. 173 (2004) 6427-6432
22. Stanton L.A., Fenhalls G., Lucas A., Gough P., Gordon S., et al. Immunophenotyping of macrophages in human pulmonary tuberculosis and sarcoidosis. Int. J. Exp. Pathol. 84 (2003) 289-304
23. Haworth R., Platt N., Keshav S., Suzuki H., et al. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J. Exp. Med. 186 (1997) 1431-1439
24. Mörmann M., Thederan M., Nackchbandi I., Giese T., Wagner C., and Hänsch G.M. Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: a link between infection and pathological bone resorption. Mol. Immunol. 45 (2008) 3330-3337
25. Tintut Y., Morony S., and Demer L.L. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 6-10
26. Miyata T., Notoya K., Yoshida K., Kurokawa K., et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J. Am. Soc. Nephrol. 8 (1997) 260-270
27. Zhou Z., Immel D., Xi C.X., Mei L., et al. Regulation of osteoclast function and bone mass by RAGE. J. Exp. Med. 203 (2006) 1067-1080
28. Arai F., Miyamoto T., Ohneda O., Brasel K., et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappa B (RANK) receptors. J. Exp. Med. 190 (1999) 1741-1754